Correction to: Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice
Target Oncol
.
2021 Nov;16(6):865.
doi: 10.1007/s11523-021-00847-w.
Authors
Adam Brufsky
1
,
Xianchen Liu
2
,
Benjamin Li
3
,
Lynn McRoy
3
,
Rachel M Layman
4
Affiliations
1
College of Medicine, University of Pittsburgh, 300 Halket St., Suite 4628, Pittsburgh, PA, 15213, USA. brufskyam@upmc.edu.
2
Pfizer Inc, New York, NY, USA. Jasonxc.Liu@pfizer.com.
3
Pfizer Inc, New York, NY, USA.
4
The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
PMID:
34652714
PMCID:
PMC9172681
DOI:
10.1007/s11523-021-00847-w
No abstract available
Publication types
Published Erratum